Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 30S prokaryotic ribosomal subunit is the smaller component of the 70S bacterial ribosome, consisting of a 16S ribosomal RNA (rRNA) strand and approximately 21 distinct ribosomal proteins [2]. It serves a fundamental role in the initiation of protein synthesis and the decoding of genetic information by ensuring accurate base-pairing between mRNA codons and tRNA anticodons [2]. Because of its essential nature and structural divergence from the eukaryotic 40S subunit, it is a primary target for diverse antibiotic classes, including aminoglycosides, tetracyclines, and spectinomycin [1, 3]. These drugs bind to specific pockets within the subunit to disrupt the translation process, effectively treating a wide range of bacterial infections [1]. However, the clinical use of 30S-targeting drugs is often complicated by the development of bacterial resistance mechanisms, such as ribosomal protection proteins or enzymatic modification of the rRNA, and potential host toxicities like damage to the kidneys or inner ear [1, 3].
Antibiotics targeting the 30S subunit inhibit protein synthesis through various mechanisms: aminoglycosides bind to the 16S rRNA A-site to cause mRNA misreading and translocation inhibition [1], while tetracyclines sterically block the A-site to prevent aminoacyl-tRNA binding [3].
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 30S prokaryotic ribosomal subunit (30S subunit) (30S subunit).